Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKore Potash PLC Regulatory News (KP2)

Share Price Information for Kore Potash PLC (KP2)

Share Price is delayed by 15 minutes
Get Live Data
3.00    0.20 (7.14%)
Bid:
2.90
Ask:
3.10
Spread: 0.20 (6.897%)
Market Cap: £155.28m
KP2 Live PriceLast checked at - London Stock Exchange

Intraday Kore Potash PLC Share Chart

Draft non-binding financing Term Sheet received

28 Apr 2025 15:23

RNS Number : 4855G
Kore Potash PLC
28 April 2025
 

28 April 2025

 

Kore Potash Plc

("Kore Potash" or the "Company")

Draft non-binding financing Term Sheet received

 

Kore Potash (AIM: KP2, ASX: KP2, JSE: KP2, A2X: KP2), the potash development company with 97% ownership of the Kola Potash Project ("Kola" or the "Kola Project") and Dougou Extension ("DX") Potash Project in the Sintoukola Basin, located in the Republic of Congo ("RoC"), is pleased to announce that, in line with previous communications, it has today received the draft financing proposal and associated draft non-binding term sheets ("Term Sheets") for the Kola Project, from the Summit Consortium ("Consortium").

 

The draft financing proposal and associated Term Sheets are comprehensive and cover the full funding requirement for the development of the Kola Project, underpinned by a combination of royalty and project finance components. Kore Potash has until 31 May 2025 to consider, negotiate if necessary and settle on the terms, following which more specific and definitive information, as appropriate, will be shared with the market.

 

The parties have agreed that no details of the proposed financing will be disclosed until the initial terms set out in the Term Sheets have been finalised, agreed and executed.

 

The Company retains the right not to accept any finance proposal presented by the Consortium and there is no guarantee that any final proposal or legally binding agreement will be forthcoming. The Company provides no assurance to shareholders that the Consortium will provide the financing required on terms which are deemed acceptable to the Company. If the Consortium does not provide an acceptable financing package leading to binding legal documentation being entered into, the Company will need to explore other debt, equity and structured finance alternatives

 

Further details about the financing arrangements will be notified to the market in accordance with the Company's continuous disclosure obligations.

 

Enquiries:

 

Kore Potash

Tel: +44 (0) 20 3963 1776

 

Andre Baya - CEO

Andrey Maruta - CFO

 

SP Angel - Nomad and Joint Broker

 

Tel: +44 (0) 20 7470 0470

Ewan Leggat

Charlie Bouverat

Grant Barker

 

Shore Capital - Joint Broker

Tel: +44 (0) 20 7408 4050

Toby Gibbs

James Thomas

Tavistock Communications

Tel: +44 (0) 20 7920 3150

Emily Moss

Nick Elwes

 

Questco Corporate Advisory - JSE Sponsor

Done Hattingh

Tel: +27 (63) 482 3802

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPKFBBQBKDKQB
Date   Source Headline
2nd Aug 20187:00 amRNSDirector Interest Notices
31st Jul 20187:01 amRNSReview of Operations for Q2 2018
31st Jul 20187:00 amRNSCashflow Report for Q2 2018
18th Jul 20189:30 amRNSCDI Monthly Movement
27th Jun 201811:01 amRNSResults of AGM
27th Jun 201811:00 amRNSExpiry of unlisted options
12th Jun 20188:45 amRNSCDI Monthly Movement
1st Jun 20188:00 amRNSAnnual Financial Report
30th May 20187:00 amRNSAppointment of CEO
23rd May 20187:00 amRNSAppointment of a Non-Executive Director
4th May 20188:00 amRNSCDI Monthly Movement
30th Apr 20189:31 amRNSReview of Operations for Q1 2018
30th Apr 20189:30 amRNSCashflow Report for Q1 2018
26th Apr 20183:40 pmRNSAdmission Document Disclosures
26th Apr 20183:37 pmRNSHolding(s) in Company
26th Apr 20181:30 pmRNSDirector Resignation
18th Apr 201810:00 amRNSExpiry of Unlisted Options
17th Apr 20189:30 amRNSDirector/PDMR Shareholding
13th Apr 20189:00 amRNSDirector/PDMR Shareholding
10th Apr 20188:00 amRNSASX waiver in relation to quotation of CDIs
9th Apr 201810:20 amRNSDirector/PDMR Shareholding
5th Apr 20181:09 pmRNSDirector/PDMR Shareholding
4th Apr 20181:55 pmRNSNotice under Section 708A
4th Apr 20181:49 pmRNSAppendix 3B
3rd Apr 20187:00 amRNSAnnual Financial Report
29th Mar 20187:00 amRNSAdmission to AIM and JSE and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.